Please login to the form below

Not currently logged in
Email:
Password:

IMS Health

This page shows the latest IMS Health news and features for those working in and with pharma, biotech and healthcare.

INC Research to merge with InVentiv Health

INC Research to merge with InVentiv Health

Combined will be second-largest outsourcing provider after QuintilesIMS. Contract research organisation INC Research and commercial services firm InVentiv Health are to combine to create the second largest biopharmaceutical outsourcing provider.

Latest news

  • Xarelto beats aspirin for recurrent blood clots Xarelto beats aspirin for recurrent blood clots

    The results could therefore provide a boost to the position in the NOAC market held by Xarelto, which according to IMS Health figures had 46.5% of the market ahead of

  • IMS Health and Quintiles complete merger IMS Health and Quintiles complete merger

    Together, information and technology company IMS Health and product development and healthcare services provider Quintiles will offer an end-to-end clinical and commercial package to pharma clients. ... IMS Health and Quintiles, which have operations in

  • Diabetes treatment 'inextricably' linked to patient education Diabetes treatment 'inextricably' linked to patient education

    Condition remains a significant burden for health systems. The successful treatment of type 2 diabetes is inextricably linked to how well patients understand their own role in managing the disease, according ... The issue is not so much in diagnosis and

  • The Digital Patient The Digital Patient

    IMS Health reported that there are escalating numbers of health apps – more than 165, 000 at last count – with 1 in 10 of them using a smartphone or some other device ... Overall, there seems little doubt that Europeans are willing to embrace digital

  • European pharma considering medicine pricing shakeup European pharma considering medicine pricing shakeup

    Oncology has been under particular focus, with IMS Health warning just last week than rising spending on cancer drugs would lead to tensions between the industry and healthcare payers.

More from news
Approximately 15 fully matching, plus 86 partially matching documents found.

Latest Intelligence

  • A digital strategy in a digital world A digital strategy in a digital world

    Across Health's 2016 survey of 275 marketeers from these industries (94% pharma) found that nearly 60% of respondents reported that the digital transformation of their organisation was moving very slowly. ... A study by IMS Health published in PME in

  • Transformational technology Transformational technology

    To examine the impact of these and other digital health trends, IMS Health and Egon Zehnder, in association with PME, convened a CIO roundtable meeting in London in March - Transforming Technology ... It is a very common idea now that pharma needs to

  • Why multichannel is not an in/out option Why multichannel is not an in/out option

    A recent IMS Health White Paper - The Essential European Revolution - outlined why multichannel is vital to pharma in Europe, but warned that the region is lagging behind the US and Japan ... However, while digital interaction in the US and Japan is

  • Multichannel: the essential European revolution Multichannel: the essential European revolution

    Sarah Rickwood is VP, European thought leadership, IMS Health,  . In association with . 12th August 2016.

  • Deal Watch May 2016 Deal Watch May 2016

    Doing the complete opposite and consolidating, Quintiles and IMS Health announced the merger of their respective businesses to form a mega-CRO with a combined market capitalisation of $17.6bn. ... 293. OPKO Health/ Vifor Fresenius. Licence. Rayaldee in EP

More from intelligence
Approximately 3 fully matching, plus 20 partially matching documents found.

Latest appointments

  • Accretio appoints Neil Levinson as strategy director Accretio appoints Neil Levinson as strategy director

    He joins the healthcare consultancy from Kaiser Associates. Accretio, part of the OPEN health group of companies, has appointed Neil Levinson as its strategy director. ... Prior to Kaiser, Levinson spent ten years at IMS Health, where he was senior

  • Medmeme bolsters its sales team Medmeme bolsters its sales team

    organisations.”. Barbalinardo has also held roles for Aileron Solutions – which was acquired by IMS Health in 2014 -, Within3, and Pfizer.

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... Jones previously worked for a variety of biotech,

  • Helen Parfitt joins Research Partnership Helen Parfitt joins Research Partnership

    Prior to joining the company, Parfitt has previously worked for IMS Health (now QuintilesIMS) as its director of core data assets, global technology services and operations, and subsequently as commercial director

  • GPI appoints commercial director GPI appoints commercial director

    Stewart joins the pharmaceutical and biotech pricing solutions firm from IMS Health, where he served as a global pricing solution specialist.

More from appointments
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics